New Iridium

Clean tech · Private

Light-driven photocatalytic system for converting CO2 into terephthalic acid

Claim this profile

Follows are private to you and power your alerts

Updated · newiridium.com

Sector
Clean tech
Total capital
$4.9M
Federal grants
$4.9M
8 awards · 2019–2023
Rank in peer group#16 of 23
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
16 pending

Capital timeline

20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $4.9M$1.5M$766K$256K$734K$1M
20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $4.9M$1.5M$766K$734K$1M

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II: Utilizing Carbon Dioxide (CO2) as a Feedstock to Produce Commodity Chemicals$1M
  • Federal grantHealth and Human S · Phase II · Organic photoredox catalysts as sustainable and cost-effective replacement forprecious metal complexes in light-driven drug synthesis$734K
  • Federal grantNSF · Phase I · STTR Phase I: Enabling Rapid Scale-up of COVID-19 Treatment using Next-Generation Light Driven Chemistry$256K
  • Federal grantHealth and Human S · Phase II · Organic photoredox catalysts as sustainable and cost-effective replacement forprecious metal complexes in light-driven drug synthesis$766K
  • Federal grantHealth and Human S · Phase II · Organic photoredox catalysts as sustainable and cost-effective replacement forprecious metal complexes in light-driven drug synthesis$1.5M
  • Federal grantNSF · Phase I · SBIR Phase I: Development and commercialization of organic photocatalysts for light-driven C-N cross-coupling reaction$225K
  • Federal grantHealth and Human S · Phase I · Organic photoredox catalysts as sustainable and cost-effective replacement for precious metal complexes in light-driven drug synthesis$225K
Show 1 earlier federal award
  • Federal grantHealth and Human S · Phase I · Organic photoredox catalysts as sustainable and cost-effective replacement for precious metal complexes in light-driven drug synthesis$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 23 peers

Line = median

Clean tech · System

  • Federal grantsBelow median
  • Linked publications#1 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 16
  • PendingCatalyst Composition For Biaryl Synthesis By Decarboxylative Cross-couplingUSPTOApplication 18306519
  • PendingUse Of A Catalyst Composition For Biaryl Synthesis By Decarboxylative Cross-couplingUSPTOApplication 18306624
  • PendingPhotoredox Catalysts And Methods Of Using Such CatalystsUSPTOApplication 17790027
Show all 16 patent records
  • Catalyst Composition For Biaryl Synthesis By Decarboxylative Cross-couplingDec 21, 2023 · Application 18306519Pending
  • Use Of A Catalyst Composition For Biaryl Synthesis By Decarboxylative Cross-couplingDec 21, 2023 · Application 18306624Pending
  • Photoredox Catalysts And Methods Of Using Such CatalystsMar 23, 2023 · Application 17790027Pending
  • Catalyst System For Suzuki Cross-coupling ReactionsMar 2, 2023 · Application 17806964Pending
  • Photocatalytic Synthesis Of A,b Unsaturated Carbonyl Compounds And Their IntermediatesApplication PCTUS2022037417Pending
  • Catalyst composition for biaryl synthesis by decarboxylative cross-couplingApplication 63366717Pending
  • Use Of A Catalyst Composition For Biaryl Synthesis By Decarboxylative Cross-couplingApplication 63366714Pending
  • Catalyst System For Suzuki Cross-coupling ReactionsApplication 63203349Pending
  • Photoredox Catalysts And Methods Of Using Such CatalystsApplication PCTUS2021012960Pending
  • Photocatalytic Carboxylation Of Alkanes With Carbon DioxideApplication 19516338Pending
  • Catalytic Oxidation Of EthanolApplication 18869524Pending
  • Photocatalytic Carboxylation Of Substrates With Carbon DioxideApplication PCTUS2024046073Pending
  • Photocatalytic Synthesis Of Alpha, Beta Unsaturated Carbonyl Compounds And Their IntermediatesApplication 18995441Pending
  • Catalytic Oxidation Of EthanolApplication PCTUS2024046071Pending
  • Photocatalytic Carboxylation Of Alkanes With Carbon DioxideApplication 63537912Pending
  • Catalytic Oxidation Of Ethanol To Acetic AcidApplication 63537919Pending

Recent research by its founders

  • Substrate-Photocatalyst Reactivity Matching Enables Broad Aryl Halide Scope in Light-Driven, Reductive Cross-Electrophile Coupling Using <sup>13</sup>C NMR as a Predictor20251 cites
  • Visible‐Light‐Promoted C−S Cross‐Coupling Reaction for Synthesis of Aromatic Thioethers20240 cites
  • Halide Noninnocence and Direct Photoreduction of Ni(II) Enables Coupling of Aryl Chlorides in Dual Catalytic, Carbon–Heteroatom Bond-Forming Reactions202348 cites
  • NEW IRIDIUM, INCShares a founder: CHERNHOOI LIM
  • Charbone Hydrogen CorpSimilar federal contract value in Clean tech · null in contracts
  • Cella Mineral Storage Inc.Similar federal contract value in Clean tech · null in contracts
  • ATERNIUM, INC.Similar federal contract value in Clean tech · null in contracts
  • T2C-ENERGY LLCSimilar federal contract value in Clean tech · null in contracts
  • 4D MAKER, LLCSimilar federal contract value in Clean tech · null in contracts

Regulatory activity · Clean tech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .